Atex Solutions Pharmaceutical Developer and Manufacturer Chooses Agitated Screw Feeder

Quelle: Pressemitteilung Ajax Equipment 1 min Reading Time

Related Vendors

Sterling Pharma Solutions has chosen Ajax Equipment for supplying an Atex-rated agitated screw feeder which is mounted on a mobile frame to feed an active pharmaceutical ingredient.

Ajax Equipment has supplied Sterling Pharma Solutions, with an Atex-rated agitated screw feeder mounted on a mobile frame to feed an active pharmaceutical ingredient. (Source:  Ajax Equipment)
Ajax Equipment has supplied Sterling Pharma Solutions, with an Atex-rated agitated screw feeder mounted on a mobile frame to feed an active pharmaceutical ingredient.
(Source: Ajax Equipment)

Solids handling equipment maker, Ajax Equipment, has supplied pharmaceutical developer and manufacturer, Sterling Pharma Solutions, with an Atex-rated agitated screw feeder mounted on a mobile frame to feed an active pharmaceutical ingredient (API).

After conducting powder flow testing to determine the material’s handling characteristics, Ajax developed the stainless-steel agitated feeder’s design to provide a reliable and controlled feed to downstream equipment. Powder is held in the agitated feeder’s hopper section, featuring a mirror finish, where the agitator promotes flow to the feed screw below without compacting the powder.

Ajax designed a robust feeder to suit the requirements and communicated well throughout design, fabrication, testing and delivery, shares Sterling Pharma Solutions.

Ajax Equipment comments that the pharmaceutical standards are some of the most demanding in solids handling but Ajax has decades of experience delivering high specification machines. In this case, the agitated feeder’s design and internal mirror finish ensure good powder slip conditions as well as making cleaning easier for the clean-in-place system. The robust construction and generous sizing of the auger ensure the machine can handle the powder while the mobile frame allows the entire feeder to be removed from the line should the requirement arise, concludes the firm.

(ID:50642133)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent